| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.26 | 1e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |